Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 3Phase 2 3Phase NA 2Phase 1/2 2Phase 2/3 1

Status

Unknown 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain, Postoperative 1Immune System Suppression 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 27Cisplatin 27Carboplatin 27Capecitabine 27camrelizumab 24Nivolumab 23apatinib 22Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 17Immunotherapy, Adoptive 17Drug Therapy 17pembrolizumab 16Docetaxel 16Dexamethasone 15Bevacizumab 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12130-nm albumin-bound paclitaxel 11anlotinib 10Fluorouracil 10Trastuzumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Morphine × Clear all
NCT04033471 2021-02-24

Combined Epidural Morphine and Midazolam on Postoperative Pain

Assiut University

Phase 1/2 Unknown
20 enrolled

Pain, Postoperative

NCT03024957 2021-01-14

Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity

Assiut University

Phase 1/2 Unknown
30 enrolled

Immune System Suppression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡